Literature DB >> 10981122

Selecting the right drug for initial antihypertensive therapy.

A B Weder1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10981122     DOI： 10.1007/s11906-000-0052-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  5 in total

Review 1.  Pharmacogenomics: translating functional genomics into rational therapeutics.

Authors:  W E Evans; M V Relling
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 2.  Clinical significance of genetic influences on cardiovascular drug metabolism.

Authors:  L Arcavi; N L Benowitz
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

3.  Normotension and hypertension: the mysterious viability of the false.

Authors:  G Pickering
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

4.  Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Authors:  J E Dickerson; A D Hingorani; M J Ashby; C R Palmer; M J Brown
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

5.  Nifedipine: individual responses and concentration-effect relationships.

Authors:  R Donnelly; H L Elliott; P A Meredith; A W Kelman; J L Reid
Journal:  Hypertension       Date:  1988-10       Impact factor: 10.190
  5 in total
  1 in total

1.  Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment.

Authors:  Diane B M A van Wieren-de Wijer; Anke-Hilse Maitland-van der Zee; Anthonius de Boer; Bruno H Ch Stricker; Abraham A Kroon; Peter W de Leeuw; O Bozkurt; Olaf H Klungel
Journal:  Pharm World Sci       Date:  2008-11-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.